tiprankstipranks
Trending News
More News >
Jbt Marel Corporation (JBTM)
:JBTM
Advertisement

JBT Marel (JBTM) AI Stock Analysis

Compare
257 Followers

Top Page

JBTM

JBT Marel

(NYSE:JBTM)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 4o)
Rating:67Neutral
Price Target:
$150.00
▲(6.78% Upside)
JBT Marel's overall stock score is driven by strong earnings call performance and effective cash flow management. However, challenges in profitability, negative valuation metrics, and mixed technical indicators weigh on the score. The company's positive guidance and strategic initiatives provide optimism for future performance.
Positive Factors
Revenue Growth
The company's strong revenue growth, driven by enhanced manufacturing and supply chain productivity, indicates robust market demand and operational efficiency, supporting long-term business expansion.
Cash Flow Management
Effective cash generation and management provide financial flexibility and stability, enabling the company to invest in growth opportunities and manage debt effectively.
Deleveraging Progress
Reducing financial leverage enhances the company's balance sheet strength, improving its ability to withstand economic fluctuations and invest in strategic initiatives.
Negative Factors
Profitability Challenges
Negative profitability margins indicate operational inefficiencies or high costs, which can hinder long-term financial health and shareholder returns if not addressed.
Tariff Impact
Tariff-related costs can erode margins and competitiveness, necessitating strategic adjustments to mitigate impacts and maintain profitability.
Mixed Regional Performance
Inconsistent regional performance may affect overall growth prospects, highlighting the need for strategic focus on underperforming markets to ensure balanced global expansion.

JBT Marel (JBTM) vs. SPDR S&P 500 ETF (SPY)

JBT Marel Business Overview & Revenue Model

Company DescriptionJBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market. In addition, it offers automated guided vehicle systems for material movement in the manufacturing, warehouse, and medical facilities. It serves baby food, bakery and confectionery, citrus processing, fruits and nuts, juices, non-food, pet food, pharmaceutical, plant- based beverages and protein, poultry, meat, and seafood, ready meals, oils, soups, sauces, seasoning and dressings, automotive, building material, tissue, paper, and packaging, hospitals, pharma and life sciences, fast moving consumer goods, manufacturing, warehousing, and other industries. The company markets and sells its products and solutions through direct sales force, independent distributors, sales representatives, and technical service teams. The company was formerly known as John Bean Technologies Corporation and changed its name to JBT Marel Corporation in January 2025. JBT Marel Corporation was incorporated in 1994 and is headquartered in Chicago, Illinois.
How the Company Makes MoneyJBT Marel generates revenue through multiple streams, including the sale of processing equipment, systems, and automation solutions to food manufacturers. The company also earns income from service contracts, maintenance, and spare parts, which provide ongoing support to its clients after the initial equipment purchase. Additionally, JBTM forms strategic partnerships with industry leaders and leverages its technological expertise to develop tailored solutions, thereby enhancing its market presence and driving sales. The recurring nature of its service agreements contributes to a stable revenue base, while new product innovations and expansions into emerging markets further bolster its earnings potential.

JBT Marel Earnings Call Summary

Earnings Call Date:Nov 03, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 24, 2026
Earnings Call Sentiment Positive
The earnings call reflected a strong performance with record revenue and significant progress in integration and synergy savings. However, tariff impacts and regional performance challenges were noted.
Q3-2025 Updates
Positive Updates
Record Revenue and Earnings
JBT Marel significantly exceeded expectations for revenue and earnings in Q3 2025. Total revenue was approximately $1 billion, a 7% sequential increase, exceeding expectations by $65 million.
Increased Orders and Backlog
JBT Marel's orders were $946 million, a 7% increase from the prior year, with strong demand in the poultry, pet food, and pharmaceutical industries. The backlog ended at $1.3 billion.
Improved EBITDA Margin
Adjusted EBITDA margin was 17.1%, exceeding expectations by 140 basis points due to favorable mix and synergy savings.
Deleveraging Progress
Financial leverage decreased from 4x to 3.1x, with expectations to be below 3x by year-end. Issued $575 million senior convertible notes, prefunding upcoming debt.
Synergy Savings and Integration
Achieved $14 million in Q3 synergy savings with expectations for $40-$45 million in-year savings. Integration of JBT and Marel is on track.
Negative Updates
Tariff Impact
Net tariff impact was approximately $15 million in Q3, expected to increase to $20 million in Q4 due to Section 232 tariffs.
Mixed Regional Performance
While demand was strong in North America, Europe and Asia saw softer sequential performance.
Company Guidance
In the third quarter of 2025, JBT Marel significantly exceeded revenue and earnings expectations, driven by enhanced manufacturing and supply chain productivity, favorable equipment mix, and accelerated synergy savings. The company raised its full-year 2025 guidance, projecting revenue between $3.76 billion and $3.79 billion and an adjusted EBITDA margin of 15.75% to 16%. Orders grew by 7% year-over-year to $946 million, with strong demand in the poultry, pet food, and pharmaceutical sectors. The backlog reached $1.3 billion, providing visibility for the remainder of the year and into 2026. Adjusted EPS for the quarter was $1.94, with synergy savings contributing $14 million. The company also made progress in reducing its financial leverage to 3.1x, aiming for below 3x by year-end. Despite an anticipated increase in tariff-related costs in the fourth quarter, JBT Marel plans to mitigate impacts through domestic production and localized supply chains, while planning to introduce new segment reporting for Protein Solutions and Prepared Food and Beverage Solutions.

JBT Marel Financial Statement Overview

Summary
JBT Marel shows strong revenue growth and effective cash flow management, but faces challenges in profitability and return on equity. The balance sheet is stable with moderate leverage, but negative net income impacts overall financial health.
Income Statement
65
Positive
JBT Marel's income statement shows a strong revenue growth rate of 24.45% in the TTM period, indicating robust top-line expansion. However, the company is facing profitability challenges, as reflected by a negative net profit margin of -5.08% and a declining EBIT margin. The gross profit margin remains stable, but the negative net income suggests operational inefficiencies or high costs impacting the bottom line.
Balance Sheet
70
Positive
The balance sheet of JBT Marel is relatively stable with a moderate debt-to-equity ratio of 0.44 in the TTM period, indicating a balanced approach to leveraging. However, the return on equity has turned negative, reflecting the impact of net losses on shareholder returns. The equity ratio remains healthy, suggesting a solid asset base relative to equity.
Cash Flow
75
Positive
JBT Marel's cash flow statement highlights a strong free cash flow growth of 34.70% in the TTM period, showcasing effective cash generation. The operating cash flow to net income ratio is positive, indicating that the company is generating cash from operations despite net losses. The free cash flow to net income ratio is also strong, suggesting efficient cash management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.26B1.72B1.66B1.59B1.40B1.73B
Gross Profit1.17B626.50M585.70M529.40M482.10M533.70M
EBITDA215.30M204.20M268.70M212.50M202.80M231.20M
Net Income-110.60M85.40M582.60M137.40M119.10M108.80M
Balance Sheet
Total Assets8.20B3.41B2.71B2.64B2.14B1.81B
Cash, Cash Equivalents and Short-Term Investments114.90M1.23B483.30M71.70M78.80M47.50M
Total Debt1.91B1.25B646.40M977.90M674.40M524.90M
Total Liabilities3.78B1.87B1.22B1.74B1.39B1.17B
Stockholders Equity4.42B1.54B1.49B905.40M750.20M637.10M
Cash Flow
Free Cash Flow216.80M195.70M-15.50M56.30M172.10M217.70M
Operating Cash Flow265.30M233.60M39.60M140.90M223.80M252.00M
Investing Cash Flow-1.79B-41.30M725.90M-416.10M-272.90M-37.30M
Financing Cash Flow1.13B561.80M-354.10M270.60M80.80M-207.40M

JBT Marel Technical Analysis

Technical Analysis Sentiment
Positive
Last Price140.47
Price Trends
50DMA
136.85
Positive
100DMA
134.95
Positive
200DMA
126.45
Positive
Market Momentum
MACD
-0.08
Negative
RSI
60.31
Neutral
STOCH
91.73
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBTM, the sentiment is Positive. The current price of 140.47 is above the 20-day moving average (MA) of 132.73, above the 50-day MA of 136.85, and above the 200-day MA of 126.45, indicating a bullish trend. The MACD of -0.08 indicates Negative momentum. The RSI at 60.31 is Neutral, neither overbought nor oversold. The STOCH value of 91.73 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JBTM.

JBT Marel Risk Analysis

JBT Marel disclosed 59 risk factors in its most recent earnings report. JBT Marel reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

JBT Marel Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$8.89B20.3420.97%1.21%3.19%69.89%
75
Outperform
$11.12B46.4312.76%12.60%24.02%
68
Neutral
$7.25B233.871.58%7.81%
67
Neutral
$7.30B-3.65%0.28%91.98%-141.14%
67
Neutral
$5.64B23.687.33%-0.75%9.22%
64
Neutral
$6.26B15.27-6.20%0.27%-159.24%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JBTM
JBT Marel
141.30
22.75
19.19%
FLS
Flowserve
69.24
10.30
17.48%
SPXC
SPX
221.92
52.83
31.24%
MIDD
The Middleby
123.20
-17.11
-12.19%
GTES
Gates Industrial
22.12
0.85
4.00%
MIR
Mirion Technologies
27.45
11.97
77.33%

JBT Marel Corporate Events

JBT Marel Corporation Reports Strong Q3 2025 Results
Nov 5, 2025

JBT Marel Corporation is a global technology solutions provider in the food and beverage industry, offering integrated systems and software to optimize food yield, safety, and efficiency across various markets.

John Bean Tech Reports Record Q3 Revenue and Earnings
Nov 5, 2025

The recent earnings call for John Bean Tech (JBT) highlighted a robust performance, marked by record revenue and significant progress in integration and synergy savings. Despite these achievements, the company acknowledged challenges related to tariff impacts and regional performance disparities.

Executive/Board Changes
JBT Marel Appoints New Principal Accounting Officer
Neutral
Oct 20, 2025

On October 15, 2025, Jessi L. Corcoran, Vice President, Corporate Controller, and Chief Accounting Officer of JBT Marel Corporation, announced her resignation effective November 4, 2025, to pursue an opportunity with another company. Her departure is amicable and not due to any disagreements with the company. Subsequently, on October 20, 2025, the Board appointed Matthew J. Meister, the Executive Vice President and Chief Financial Officer, as the new principal accounting officer effective upon Ms. Corcoran’s departure. Mr. Meister, who has been with the company since 2019, will not receive additional compensation for this role, and there are no special arrangements or family ties influencing his appointment.

The most recent analyst rating on (JBTM) stock is a Hold with a $144.00 price target. To see the full list of analyst forecasts on JBT Marel stock, see the JBTM Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
JBT Marel Completes $575M Convertible Notes Offering
Positive
Sep 9, 2025

On September 9, 2025, JBT Marel Corporation completed a private offering of $575 million in convertible senior notes due 2030, which includes additional notes acquired by initial purchasers. The company plans to use the net proceeds to repay part of its revolving credit facility and refinance its outstanding convertible senior notes due 2026. This strategic financial move is expected to strengthen JBT Marel’s financial position and support its ongoing operations and growth initiatives in the food and beverage technology sector.

The most recent analyst rating on (JBTM) stock is a Buy with a $156.00 price target. To see the full list of analyst forecasts on JBT Marel stock, see the JBTM Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
JBT Marel Announces Credit Agreement Amendment and Note Offering
Neutral
Sep 3, 2025

On September 3, 2025, JBT Marel Corporation announced a Second Amendment to its Credit Agreement, reducing pricing for its Revolving Credit Facility and allowing issuance of up to $600 million in unsecured convertible notes. Concurrently, the company announced a private offering of $500 million in convertible senior notes due 2030, with an option for an additional $75 million. The proceeds will be used for convertible note hedge transactions and to repay existing debt, potentially impacting the company’s financial strategy and market positioning.

The most recent analyst rating on (JBTM) stock is a Buy with a $156.00 price target. To see the full list of analyst forecasts on JBT Marel stock, see the JBTM Stock Forecast page.

Private Placements and Financing
JBT Marel Amends Credit Agreement to Lower Loan Costs
Positive
Aug 21, 2025

On August 20, 2025, JBT Marel Corporation, a Delaware corporation, executed an amendment to its Second Amended and Restated Credit Agreement to reduce the pricing of its Term B Loans. This amendment removes a ten basis point credit spread adjustment and lowers the applicable margin from SOFR plus 2.00%-2.50% to SOFR plus 1.75%, depending on the company’s Total Net Leverage Ratio. The agreement was executed with various parties including John Bean Technologies Corporation Europe B.V., its subsidiary guarantors, lenders, and Wells Fargo Bank as the administrative agent.

The most recent analyst rating on (JBTM) stock is a Hold with a $144.00 price target. To see the full list of analyst forecasts on JBT Marel stock, see the JBTM Stock Forecast page.

JBT Marel Corporation Exceeds Q2 2025 Expectations
Aug 6, 2025

JBT Marel Corporation is a global technology solutions provider specializing in high-value segments of the food and beverage industry, offering cutting-edge technology, systems, and software to optimize food yield and efficiency while reducing waste across the global food supply chain.

John Bean Tech’s Strong Q2 and Optimistic Outlook
Aug 6, 2025

The recent earnings call for John Bean Tech (JBT) reflected an overall positive sentiment, highlighting strong performance in the second quarter of 2025. The company demonstrated significant progress in synergies, improved cash flow, and reduced leverage. However, challenges such as tariff costs, geographic performance variability, and softness in certain segments were also acknowledged.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025